Related Experiment Video
Updated: Jan 1, 2026

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
The Role of MicroRNAs in the Pathogenesis of Diabetic Nephropathy
Jian Tang1, Deyi Yao2, Haiying Yan2
1Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610075, Sichuan, China.
Abstract:
Diabetic nephropathy (DN) is one of the most common microvascular complications in diabetic patients; it is also an important cause of renal dysfunction, renal fibrosis, and end-stage renal disease. Unfortunately, the pathogenesis of DN is complex and has not yet been fully elucidated; hence, the pathogenesis of DN to determine effective treatments of crucial importance is deeply explored. Early DN research focuses on hemodynamic changes and metabolic disorders, and recent studies have shown the regulatory role of microRNAs (miRNAs) in genes, which may be a new diagnostic marker and therapeutic target for diabetic nephropathy. In this review, we summarize the recent advances in the clinical value and molecular mechanisms of miRNAs in DN, providing new ideas for the diagnosis and treatment of DN.
Insights
Diabetic nephropathy (DN) is a serious kidney complication in diabetes. MicroRNAs (miRNAs) show promise as new diagnostic markers and therapeutic targets for DN, offering novel treatment strategies.
Area of Science:
- Nephrology
- Molecular Biology
- Genetics
Background:
- Diabetic nephropathy (DN) is a leading cause of kidney disease and end-stage renal disease in diabetic patients.
- The complex pathogenesis of DN necessitates further research for effective treatments.
- Traditional research focused on hemodynamic and metabolic factors in DN.
Purpose of the Study:
- To review recent advances in understanding the clinical value and molecular mechanisms of microRNAs (miRNAs) in diabetic nephropathy.
- To explore miRNAs as potential diagnostic markers and therapeutic targets for DN.
- To provide new insights for the diagnosis and treatment of DN.
Main Methods:
- Literature review of recent studies on miRNAs in diabetic nephropathy.
- Analysis of the regulatory roles of miRNAs in gene expression related to DN.
- Synthesis of information on the clinical value and molecular mechanisms of miRNAs in DN.
Main Results:
- MicroRNAs (miRNAs) play a significant regulatory role in gene expression relevant to DN.
- Emerging evidence suggests miRNAs can serve as novel diagnostic biomarkers for DN.
- miRNAs present potential as therapeutic targets for managing DN.
Conclusions:
- MicroRNAs represent a promising frontier in the diagnosis and treatment of diabetic nephropathy.
- Further research into miRNA mechanisms can lead to innovative therapeutic strategies for DN.
- Understanding miRNA's role in DN offers new avenues for clinical intervention.
More Related Videos
07:01Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
Published on: May 10, 2022
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Related Concept Videos
MicroRNAs
MicroRNAs
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Fungal Phylum Microsporidia